USC/Norris Comprehensive Cancer Center
USC/Norris
About USC/Norris
Patient Care
Research
Clinical Trials
Search Trials
Faculty
Education
Future at USC/Norris
Core Facilities
Support USC/Norris
» Contact Us
» Glossary
» Make a Donation
If you are a patient, please contact
The Doctors of USC
at 800-USC-CARE.
Details for trial 3C-09-2
Description:
A Multi-Center, Open-Label, Randomized, Phase II Study to Evaluate the Efficacy and Safety of NKTR-102 (PEG-Irinotecan) versus Irinotecan in Patients with Second-Line, Irinotecan-Naïve, KRAS-Mutant, Colorectal Cancer with Metastatic or Locally Advanced Disease.
Status:
Open
Randomized?
Yes
Researchers
Principal Investigator
Title
Heinz Josef Lenz
M.D.
Data Management
Name
Title
Ramona Lujan
R.N.
San Aye
D.M.
Yordy Brito
D.M.
Carol Jones
R.N.
You may participate in this study if:
(No criteria found)
You may not participate in this study if:
(No criteria found)
For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.
